Dr Sydney E Pulver, MD | |
1714 Locust St, Suite 2, Philadelphia, PA 19103-6107 | |
(215) 545-7717 | |
Not Available |
Full Name | Dr Sydney E Pulver |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 1714 Locust St, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003059692 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MD-004464-E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sydney E Pulver, MD 1714 Locust St, Suite 2, Philadelphia, PA 19103-6107 Ph: (215) 545-7717 | Dr Sydney E Pulver, MD 1714 Locust St, Suite 2, Philadelphia, PA 19103-6107 Ph: (215) 545-7717 |
News Archive
AMN Healthcare Services, Inc. announced it has completed the sale of its home healthcare business to BAYADA Home Health Care, Inc. effective January 30, 2012. As a result of the sale, AMN will receive cash proceeds of $9.65 million and retain working capital of approximately $4 million.
Bilingual learning can provide substantial benefits for second and third generation children whose families speak a language other than English, according to ESRC-funded research by Goldsmiths, University of London.
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.
Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that up to one-third of rheumatoid arthritis patients discontinue or change therapy within the first year of treatment.
› Verified 8 days ago
Meredith A Spindler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3900 Woodland Ave, Padrecc, #127, Philadelphia, PA 19104 Phone: 215-823-5800 Fax: 215-823-5815 | |
Dr. Ly Thien Ngo, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 909 Walnut Street, 2nd Floor, Philadelphia, PA 19107 Phone: 215-955-1234 Fax: 215-923-6792 | |
Dr. Samantha Megan Wyckoff, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 111 N 49th St, Philadelphia, PA 19139 Phone: 215-471-2600 | |
Robert Eric Simons, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 100 E Lehigh Ave, Philadelphia, PA 19125 Phone: 215-707-1200 | |
Eileen Zhou, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 100 E Lehigh Ave, Philadelphia, PA 19125 Phone: 215-707-1200 | |
Madhulatha Paul, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 E Lehigh Ave, Mab Bldg Ste 105, Philadelphia, PA 19125 Phone: 215-707-8496 Fax: 215-707-4086 |